Clinical analysis of ribavirin combined with xuebijing in treating 31 patients with severe hemorrhagic fever with renal syndrome
10.7619/jcmp.201801041
- VernacularTitle:利巴韦林联合血必净治疗重症肾综合征出血热31例临床分析
- Author:
Zhiping WEI
1
;
Ronghua WANG
;
Xulei ZHANG
;
Qingyu YANG
;
Yangjuan PU
Author Information
1. 江苏省南京市高淳人民医院
- Keywords:
hemorrhagic fever with renal syndrome;
ribavirin;
xuebijing
- From:
Journal of Clinical Medicine in Practice
2018;22(1):131-132,135
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical effect of ribavirin combined with xuebijing on the treatment of patients with severe hemorrhagic fever with renal syndrome (HFRS).Methods Totally 61 patients with HFRS were randomly divided into two groups.The treatment group was treated with ribavirin and xuebijing,while the control group was treated with ribavirin.Results The descent speed of serum procalcitonin in the treatment group was significantly higher than the control group (P ＜ 0.05).The recovery time of platelet,the recovery time of serum creatinine,the time of Hypotension shock,oliguria time and polyuria time in the treatment group were significantly shorter than the control group (P ＜ 0.05).Conclusion The clinical efficacy of ribavirin combined with xuebijing is better than single application of ribavirin in the treatment of patients with HFRS.
